SecBot SecBot

CASIF

CASI Pharmaceuticals, Inc.
OTC· Pharmaceutical Preparations· Inc. E9· CIK 0001962738 Biotech & Drug Discovery
$0.1000 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.1000
Median target
$4.00
+3900% · range $4.00–4.00
Next earnings
Nov 12
in 16 days
1 year
−93.8%
from $1.62 · Oct 27
30 days
−16.7%
from $0.1200
52-week range
$0.1000–1.62
−94% from high · low Jun 9
Avg volume 20D
1.6K
Oct 22 spike 5.2K
Short interest
🔒 Subscribers only
Filing reports
10
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 1 bearish · 1 bullish oldest → newest, height = score
Avg score ·High conf. 1/2 ·Next Earnings date, Nov 12, 2026
Strongest BULLISH CASI Pharmaceuticals sold its equity interests in Alesta Therapeutics to BioMarin Pharmaceutical for…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • TrendDOWNTREND

    19% below its 50-day average. New closing low $0.1000 on Oct 26.

The Street

last action Sep 2025
12-month targets · 1 analysts

Price is below the lowest target. Median implies +3900%.Targets as of Jul 8, 2026.

Recent actions
DateFirmActionRating
Sep 3, 2025HC Wainwright & Co.
REITERATE
REITERATEBuy
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 2, 2026 SEC
CASI Pharmaceuticals sold its equity interests in Alesta Therapeutics to BioMarin Pharmaceutical for approximately…
6-K — Impact 6/10
Aug 27, 2026 Earnings calendar
CASIF Q2 2026 Earnings Scheduled — 2026-08-27
Aug 14, 2026 SEC
CASI Pharmaceuticals reported H1 2026 results with revenue declining 5.8% to $9.8M, net loss narrowing to $20.0M from…
6-K — Impact 6/10
Jul 15, 2026 SEC
CASI Pharmaceuticals won a final arbitration award against Juventas, with the tribunal rejecting all of Juventas'…
6-K — Impact 7/10

Earnings setup

Estimates
Nov 12
reports in 16 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
CASIF Q3 2026 Earnings Scheduled — 2026-11-12
Recent
Aug 27, 2026
Earnings date
CASIF Q2 2026 Earnings Scheduled — 2026-08-27
Jun 30, 2026
Earnings date
CASIF Q1 2026 Earnings Scheduled — 2026-06-30

SecBot reports

10 filings · 3 bullish · 2 bearish · 5 neutral
All CASIF filing & press-release reports (10)